EP 2081907 A1 20090729 - ARYL PIPERAZINE DERIVATIVES USEFUL FOR THE TREATMENT OF NEUROPSYCHIATRY DISORDERS
Title (en)
ARYL PIPERAZINE DERIVATIVES USEFUL FOR THE TREATMENT OF NEUROPSYCHIATRY DISORDERS
Title (de)
FÜR DIE BEHANDLUNG VON NEUROPSYCHIATRISCHEN STÖRUNGEN GEEIGNETE ARYLPIPERAZINDERIVATE
Title (fr)
DERIVES D'ARYLPIPERAZINE UTILES POUR LE TRAITEMENT DE TROUBLES NEUROPSYCHIATRIQUES
Publication
Application
Priority
- EP 2007060888 W 20071012
- DK PA200601328 A 20061013
- US 85131006 P 20061013
Abstract (en)
[origin: WO2008043839A1] This invention provides novel aryl piperazine derivatives represented by Formula (I) having medical utility, in particular as modulators of dopamine and serotonin receptors, preferably the D<SUB>3</SUB>, 5HT<SUB>1A</SUB> and 5-HT<SUB>2A</SUB> receptor subtypes, and in particular useful for the treatment of neuropsychiatric disorders, incl. schizophrenia.
IPC 8 full level
C07D 215/48 (2006.01); A61K 31/4709 (2006.01); A61P 25/18 (2006.01)
CPC (source: EP US)
A61P 15/08 (2017.12 - EP); A61P 21/00 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/04 (2017.12 - EP); A61P 25/14 (2017.12 - EP); A61P 25/16 (2017.12 - EP); A61P 25/18 (2017.12 - EP); A61P 25/20 (2017.12 - EP); A61P 25/22 (2017.12 - EP); A61P 25/24 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 25/30 (2017.12 - EP); A61P 25/36 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07D 215/48 (2013.01 - EP US)
Citation (search report)
See references of WO 2008043839A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2008043839 A1 20080417; AU 2007306274 A1 20080417; CA 2672920 A1 20080417; EP 2081907 A1 20090729; EP 2081907 B1 20110126; JP 2010505919 A 20100225; MX 2009003390 A 20090409; US 2010087445 A1 20100408
DOCDB simple family (application)
EP 2007060888 W 20071012; AU 2007306274 A 20071012; CA 2672920 A 20071012; EP 07821255 A 20071012; JP 2009531858 A 20071012; MX 2009003390 A 20071012; US 44537007 A 20071012